2026 Swedish Health Economics Conference (SHEA)
Michael Willis, our partner from IHE – The Swedish Institute for Health Economics, spoke last week at the 2026 Swedish Health Economics Conference (SHEA) in Lund, addressing key challenges in cost-effectiveness modelling for precision oncology.
As cancer care shifts toward biomarker-driven, AI-supported treatment decisions, many existing NSCLC models still overlook diagnostic performance and misclassification, despite their critical impact on patient outcomes.
Based on a review of 237 published models, this work calls for a shift toward modelling treatment strategies, linking decision rules, treatment assignment, and patient pathways over time.
It also highlights the role of open-source platforms in improving transparency, validation, and collaboration in increasingly complex decision-making.
HealthEconomics EuropeanFundedProject
Stay tuned for more information and don’t forget to follow us on our social networks:
LinkedIn | Twitter | Instagram | Facebook
Share on: